Axio Biosolutions
Axio is a medtech R&D and Manufacturing Company focused on Advanced Surgical and wound care. Axio has the distinction to be the first company from India to get USFDA clearance for a woundcare/hemostat product. Controlling life threatening bleeding continues to be the major cause of death from traumatic injuries. Axiostat is its flagship product developed to reduce the mortality due to traumatic bleeding. A CE approved product, Axiostat is based on a patented novel 100% chitosan platform and has variants catering to Emergency & Trauma, Military, Cardio-vascular and Dental applications.
Domain
axiobio.com
Country
United StatesIndustry
Emergency MedicineEmployees
101-250
Last Funding
$6.0M
Founded
2008
Tech Stack (14 technologies)
Frequently Asked Questions
What technologies does Axio Biosolutions use?+
Axio Biosolutions uses 14 technologies including Google Analytics, Google Tag Manager, Lenis.
What industry is Axio Biosolutions in?+
Axio Biosolutions operates in the Emergency Medicine industry.
Where is Axio Biosolutions based?+
Axio Biosolutions is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026